Management

FDA Will Hold Public Hearing May 31 On CBD

May 30, 2019

Kimzy Nanney 1562047 Unsplash 5ceffa4b3e322

The Food and Drug Administration will hold a public hearing May 31 regarding products containing cannabis or cannabis-derived compounds, like CBD, The National Law Review reports. The agenda for the hearing and a webcast are publicly available. The FDA would like comments by July 2 about any health or safety risks and information about production and marketing regarding CBD, which can be posted here.

Management

Mainstream CBD Acceptance Being Driven By Boomers And Millennials

May 9, 2019

NEW YORK, May 7, 2019 /PRNewswire/ -- Sales of cannabidiol (CBD) oil are dramatically rising across North America, as its availability on mainstream shelves caters to growing ...

Heather A. Bailey and Darren Grady, two partners at SmithAmundsen LLC

Management

FDA Softening Stance On CBD? What Is In Store For Vending Employers?

May 8, 2019

While many following the rise of the cannabis industry in the United States have seen CBD-infused food and drink products hitting the market, what many may not know is that CBD...

Food

FDA Commissioner Makes Statement On Agency's New Steps In Evaluating Regulation Of Cannabis-Containing, Cannabis-Derived Products

April 3, 2019

April 2, 2019In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L....